SCHEMBL16421959

SCHEMBL16421959

CCOC(=O)Cn1c(C)nc2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.73
▸ HSD17B10 Q99714 3/20 0.73
▸ ALDH1A1 P00352 8/20 0.67
▸ HPGD P15428 3/20 0.67
▸ HTT P42858 3/20 0.67
▸ TSHR P16473 3/20 0.65
▸ SAE1 Q9UBE0 1/20 0.62
▸ UBA2 Q9UBT2 1/20 0.62
▸ GAA P10253 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ MAPT P10636 1/20 0.59
▸ CYP2C19 P33261 2/20 0.57
▸ THRB P10828 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ KLK6 Q92876 1/20 0.56
▸ PTGDR2 Q9Y5Y4 1/20 0.56
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ GSK3B P49841 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12495433 0.87 ALDH1A1 (0.72) KDM4EHSD17B10ALDH1A1HTTTSHR
SCHEMBL569988 0.86 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL22965266 0.86 KDM4E (0.59) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL28287010 0.85 KDM4E (0.78) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL14648187 0.83 KDM4E (0.79) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL16421862 0.83 GAA (0.59) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL30951936 0.83 ALDH1A1 (0.64) KDM4EHSD17B10ALDH1A1HTTTSHR
SCHEMBL3976738 0.82 KDM4E (0.65) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL22965212 0.82 PTGDR2 (0.59) KDM4EHSD17B10ALDH1A1HPGDHTT
SCHEMBL29427371 0.82 TSHR (0.55) KDM4EHSD17B10ALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021023796-A1 COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING HETEROCYCLIC COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS POLYPLUS TRANSFECTION (FR) 2021-02-11 — — WO disclosed
WO-2015011331-A1 USE OF COMPOUNDS DERIVED FROM PYRIDAZINO[1',6':1,2]PYRIDO[3,4-B]INDOLE AND PYRIDAZINO[3,2-B]BENZIMIDAZOLE SALTS AS ANTI-INFLAMMATORY AGENTS FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO LA PAZ (FIBHULP) (ES) 2015-01-29 — — WO disclosed
Send feedback